Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant

Jonathan Ofer, Genady Drozdinsky, Bar Basharim, Adi Turjeman, Noa Eliakim-Raz, Salomon M. Stemmer

Open source

DOI
10.1001/jamaoncol.2023.5042
Published
2024-01-01
Container
JAMA Oncology
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2023.5042,
  title = {Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant},
  author = {Jonathan Ofer and Genady Drozdinsky and Bar Basharim and Adi Turjeman and Noa Eliakim-Raz and Salomon M. Stemmer},
  year = {2024},
  journal = {JAMA Oncology},
  doi = {10.1001/jamaoncol.2023.5042},
  url = {https://doi.org/10.1001/jamaoncol.2023.5042}
}

RIS

TY  - JOUR
TI  - Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant
AU  - Jonathan Ofer
AU  - Genady Drozdinsky
AU  - Bar Basharim
AU  - Adi Turjeman
AU  - Noa Eliakim-Raz
AU  - Salomon M. Stemmer
PY  - 2024
JO  - JAMA Oncology
DO  - 10.1001/jamaoncol.2023.5042
UR  - https://doi.org/10.1001/jamaoncol.2023.5042
ER  - 

APA

Ofer, J., Drozdinsky, G., Basharim, B., Turjeman, A., Eliakim-Raz, N., & Stemmer, S. M. (2024). Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2023.5042

Source records